<html><head></head><body><h1>Multi Vitamin Infusion M.V.I. 12</h1><p class="drug-subtitle"><b>Dosage Form:</b> injection, solution<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Professional</li>
<li>Interactions</li>
<li>Reviews</li>
<li>Images</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Indications and Usage</li>
<li>Dosage and Administration</li>
<li>Dosage Forms and Strengths</li>
<li>Contraindications</li>
<li>Warnings and Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li>Drug Interactions</li>
<li class="ddc-toggle-hidden">Use In Specific Populations</li>
<li class="ddc-toggle-hidden">Overdosage</li>
<li class="ddc-toggle-hidden">Description</li>
<li class="ddc-toggle-hidden">Nonclinical Toxicology</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
<li class="ddc-toggle-hidden">Patient Counseling Information</li>
</ul><h2>Indications and Usage for Multi Vitamin Infusion M.V.I. 12</h2><p class="First"><span class="Emphasis"><span class="Bold">M.V.I.-12™ Pharmacy Bulk Package (Multi-Vitamin Infusion without vitamin K)</span></span> is indicated for the prevention of vitamin deficiency in adults and children aged 11 years and above on warfarin anticoagulant therapy receiving parenteral nutrition.</p><p>The physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy.</p><h2>Multi Vitamin Infusion M.V.I. 12 Dosage and Administration</h2><h3>2.1 Starting Dose, Dose Range and Route of Administration</h3><p class="First"><span class="following_xmChange">The starting dose is one 10 mL daily dose added directly to an intravenous fluid. Patients with multiple vitamin deficiencies or with increased vitamin requirements may need multiple daily dosages as indicated. Some patients do not maintain adequate levels of certain vitamins when this formulation in recommended amounts is the only source of vitamins. </span></p><h3>Monitoring</h3><p class="First">Blood vitamin concentrations should be monitored to ensure maintenance of adequate levels, particularly in patients receiving parenteral multivitamins as the only source of vitamins for long periods of time.</p><h3>2.3 Instructions for Intravenous Administration</h3><p class="First"><span class="following_xmChange">The solution must be prepared prior to intravenous administration.</span></p><h3>2.4 Drug Incompatibilities</h3><h2>Dosage Forms and Strengths</h2><p class="First">M.V.I.-12™ Pharmacy Bulk Package is a sterile product consisting of two vials labeled Vial 1 (50 mL) and Vial 2 (50 mL). The mixed solution (100 mL) will provide ten 10 mL single doses [<span class="Italics"><span class="Emphasis">see</span> Description (11)</span>].</p><h2>Contraindications</h2><p class="First">M.V.I.-12™ is contraindicated in patients who have a history of hypersensitivity to any of the vitamins in this product or existing hypervitaminosis due to any vitamins contained in this formulation.</p><h2>Warnings and Precautions</h2><h3>5.1 Aluminum Toxicity</h3><p class="First"><span class="following_xmChange">M.V.I.-12™ contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.</span></p><p><span class="following_xmChange">Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 microgram per kg per day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.</span></p><h3>5.2 Adherence of Vitamin A to Plastic</h3><p class="First"><span class="following_xmChange">Studies have shown that vitamin A, which is found in M.V.I.-12™ may adhere to polyvinyl chloride (PVC) plastic, resulting in lower vitamin A concentrations in the administered M.V.I.-12™ doses. Therefore, blood vitamin concentrations should be periodically monitored and the administration of additional therapeutic doses of Vitamin A may be required [<span class="Italics">see</span></span> <span class="Italics">Warnings and Precautions (5.7)</span><span class="following_xmChange">].</span><br/></p><h3>5.3 Intravenous Fat Emulsions</h3><p class="First"><span class="following_xmChange">Do not add M.V.I.-12™ directly to intravenous fat emulsions.</span></p><h3>5.4 Allergic Reactions to Thiamine</h3><p class="First"><span class="following_xmChange">Allergic reactions such as urticaria, periorbital and digital edema, have been reported following intravenous administration of thiamine, which is found in M.V.I.-12™. There have been rare reports of anaphylactoid reactions following intravenous doses of thiamine. No fatal anaphylactoid reactions associated with M.V.I.-12™ have been reported.</span></p><h3>5.5 Hypervitaminosis A</h3><p class="First"><span class="following_xmChange">Hypervitaminosis A, manifested by nausea, vomiting, headache, dizziness, blurred vision, has been reported in patients with renal failure receiving 1.5 mg/day retinol and in patients with liver disease. Therefore, supplementation of renal failure patients and patients with liver diseases with vitamin A, an ingredient found in M.V.I.-12™, should be undertaken with caution [<span class="Italics">see</span></span> <span class="Italics">Use in Specific Populations (8.6 and 8.7)</span><span class="following_xmChange">].</span></p><h3>5.6 Blood Sampling of Megaloblastic Anemia Patients</h3><p class="First"><span class="following_xmChange"><span class="Bold">Do not administer M.V.I.-12™ to patients with suspected or diagnosed megaloblastic anemia prior to blood sampling for the detection of the folic acid and cyanocobalamin deficiencies.</span> The folic acid and the cyanocobalamin in the M.V.I.-12™ solution can mask serum deficits of folic acid and cyanocobalamin in these patients.</span></p><h3>5.7 Monitor Blood Vitamin Concentrations</h3><p class="First"><span class="following_xmChange">In patients receiving parenteral multivitamins, such as with M.V.I.-12™, blood vitamin concentrations should be periodically monitored to determine if vitamin deficiencies or excesses are developing. M.V.I.-12™ may not correct long-standing specific vitamin deficiencies. The administration of additional therapeutic doses of specific vitamins may be required [<span class="Italics">see</span></span> <span class="Italics">Dosage and Administration (2.2)</span><span class="following_xmChange">]. </span></p><h3>5.8 Interference with Urine Glucose Testing</h3><p class="First"><span class="following_xmChange">M.V.I-12™ contains Vitamin C which is also known as ascorbic acid. Ascorbic acid in the urine may cause false negative urine glucose determinations.</span></p><h2>Adverse Reactions</h2><p class="First">The following adverse reactions are discussed in greater detail in other section of the labeling.</p><p><span class="Emphasis"><span class="Bold">Other adverse reactions:</span></span></p><p><span class="Emphasis"><span class="Italics">Dermatologic</span></span>: rash, erythema, pruritus<br/>
<span class="Emphasis"><span class="Italics">CNS</span></span>: headache, dizziness, agitation, anxiety<br/>
<span class="Emphasis"><span class="Italics">Ophthalmic</span></span>: diplopia</p><h2>Drug Interactions</h2><p class="First">A number of drug interactions between vitamins and other drugs have been reported. Consult appropriate references for additional specific vitamin-drug interactions. The following are examples of these types of interactions:</p><h3>Clinical Interactions Affecting Drug Levels</h3><p class="First"><span class="Emphasis"><span class="Bold">Folic acid</span></span></p><p>Phenytoin metabolism may be increased by folic acid. Low serum concentration of phenytoin may result in increased seizure frequency.</p><p>Patient’s response to methotrexate therapy may be decreased by folic acid.</p><p><span class="Emphasis"><span class="Bold">Pyridoxine</span></span></p><p>The metabolism of levodopa may be increased and its efficacy may be decreased by pyridoxine.</p><p><span class="Emphasis"><span class="Bold">Antibiotics</span></span></p><p>Antibiotic activity of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin is decreased by thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid. Bleomycin is inactivated <span class="Emphasis"><span class="Italics">in vitro</span></span> by ascorbic acid and riboflavin.</p><h3>Clinical Interactions Affecting Vitamin Levels</h3><p class="First"><span class="Emphasis"><span class="Bold">Hydralazine, Isoniazid</span></span></p><p>Pyridoxine requirements may be increased by concomitant administration of hydralazine or isoniazid.</p><p><span class="Emphasis"><span class="Bold">Chloramphenicol</span></span></p><p>In patients with pernicious anemia, the hematologic response to vitamin B<span class="Sub">12</span> therapy may be inhibited by concomitant administration of chloramphenicol.</p><p><span class="Emphasis"><span class="Bold">Phenytoin</span></span></p><p>Serum folic acid concentrations may be decreased by phenytoin and, therefore it should be avoided in pregnancy.</p><h2>USE IN SPECIFIC POPULATIONS</h2><h3>Pregnancy</h3><p class="First">M.V.I.-12™ has not been studied in pregnant women. Pregnant women should follow the U.S. Recommended Daily Allowances for their condition, because their vitamin requirements may be different than nonpregnant women.</p><h3>Nursing Mothers</h3><p class="First">M.V.I.-12™ has not been studied in lactating women. Lactating women should follow the U.S. Recommended Daily Allowances for their condition, because their vitamin requirements may be different than a nonlactating woman. Caution should be exercised when M.V.I.-12™ Pharmacy Bulk Package is administered to a nursing woman.</p><h3>Pediatric Use</h3><p class="First">Safety and effectiveness of M.V.I.-12™ in children below the age of 11 years have not been established.</p><h3>Patients with Renal Impairment</h3><p class="First">M.V.I.-12™ has not been studied in patients with renal impairment. Monitor renal function, calcium, phosphorus and vitamin A levels in patients with renal impairment [<span class="Italics"><span class="Emphasis">see</span> Warning and Precautions (5.1, 5.5)</span>]<span class="Emphasis"><span class="Italics">.</span></span></p><h3>Patients with Liver Impairment</h3><p class="First">M.V.I.-12™ has not been studied in patients with liver impairment. Monitor vitamin A level in patients with liver disease, high alcohol consumption [<span class="Italics"><span class="Emphasis">see</span> Warning and Precautions (5.5)</span>]<span class="Emphasis"><span class="Italics">.</span></span></p><h2>Overdosage</h2><p class="First">There is no clinical experience with M.V.I.-12™ overdosage. Signs and symptoms of acute or chronic overdosage may be those of individual M.V.I.-12™ component toxicity.</p><h2>Multi Vitamin Infusion M.V.I. 12 Description</h2><p class="First">M.V.I.-12™ Pharmacy Bulk Package: A sterile product consisting of two Type 1, amber glass vials labeled Vial 1 (50 mL) and Vial 2 (50 mL). The mixed solution will provide ten single doses of 10 mL each.</p><p class="First"><span class="Emphasis"><span class="Bold">Vial 1*</span></span></p><p class="First"><span class="Emphasis"><span class="Bold">Ingredient</span></span></p><p class="First"><span class="Emphasis"><span class="Bold">Amount per Unit Dose</span></span></p><p class="First"><span class="Emphasis"><span class="Bold">Fat Soluble Vitamins**</span></span></p><p class="First">Vitamin A (retinol)</p><p class="First">1 mg (3,300 USP units)</p><p class="First">Vitamin D (ergocalciferol)</p><p class="First">5 mcg (200 USP units)</p><p class="First">Vitamin E (dl-alpha-tocopheryl acetate)</p><p class="First">10 mg (10 USP units)</p><p class="First"><span class="Emphasis"><span class="Bold">Water Soluble Vitamins</span></span></p><p class="First">Vitamin C (ascorbic acid)</p><p class="First">200 mg</p><p class="First">Niacinamide</p><p class="First">40 mg</p><p class="First">Vitamin B<span class="Sub">2</span> (as riboflavin 5-phosphate sodium)</p><p class="First">3.6 mg</p><p class="First">Vitamin B<span class="Sub">1</span>(thiamine)</p><p class="First">6 mg</p><p class="First">Vitamin B<span class="Sub">6</span> (pyridoxine HCl)</p><p class="First">6 mg</p><p class="First">Dexpanthenol (d-pantothenyl alcohol)</p><p class="First">15 mg</p><p class="First"><span class="Bold"><span class="Emphasis">Vial 2</span>*</span></p><p class="First"><span class="Emphasis"><span class="Bold">Ingredient</span></span></p><p class="First"><span class="Emphasis"><span class="Bold">Amount per Unit Dose</span></span></p><p class="First">Biotin</p><p class="First">60 mcg</p><p class="First">Folic acid</p><p class="First">600 mcg</p><p class="First">Vitamin B<span class="Sub">12</span> (cyanocobalamin)</p><p class="First">5 mcg</p><p>“Aqueous” multivitamin formula for intravenous infusion: M.V.I.-12™ (Multi-Vitamin Infusion without vitamin K) makes available a combination of important fat-soluble and water-soluble vitamins in an aqueous solution, formulated specially for incorporation into intravenous infusions. Through special processing techniques, the liposoluble vitamins A, D, and E have been solubilized in an aqueous medium with polysorbate 80, permitting intravenous administration of these vitamins.</p><h2>Nonclinical Toxicology</h2><h3>Carcinogenesis, Mutagenesis, Impairment of Fertility</h3><p class="First">Carcinogenicity, mutagenicity and fertility studies were not performed.</p><h2>How Supplied/Storage and Handling</h2><p class="First"><span class="Emphasis"><span class="Bold">M.V.I.-12™ PHARMACY BULK PACKAGE</span></span></p><p class="First"><span class="Bold">Unit of Sale</span></p><p class="First"><span class="Bold">Concentration</span></p><p class="First"><span class="Bold">Intermediate</span></p><p><span class="Bold">Multi-Pack</span></p><p class="First"><span class="Bold">Each</span></p><p><span class="Bold">(Vial 1 and Vial 2)</span></p><p class="First"><span class="Bold">NDC 61703-423-83</span></p><p>Case of 2 Boxes of 10 vials</p><p>(5 vial 1 and 5 vial 2)</p><p class="First">Multi-Vitamin Infusion - 12 (Pharmacy Bulk Package)</p><p class="First">NDC 61703-423-78</p><p>Box of 10 vials (5 vial 1 and 5 vial 2)</p><p class="First">NDC 61703-423-73</p><p>50 mL</p><p>(vial 1 and vial 2) multiple dose vial</p><p>Mix contents of Vial 1 and Vial 2 to provide ten 10 mL single doses.</p><p>Minimize the exposure of M.V.I.-12™ to the light, because vitamins A, D and riboflavin are light sensitive.</p><p>Store at 2-8°C (36-46°F).</p><h2>Patient Counseling Information</h2><p class="First"> </p><p>                                                                              EN-3669</p><p>Manufactured by                                                                                                                             <br/>
Hospira, Inc., Lake Forest, IL 60045 USA</p><h2>CA-3654 Front</h2><h2>CA-3654 Back</h2><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is Foltanx prescribed for?</li>
</ul><h2>More about multivitamin</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>En Español</li>
<li>153 Reviews</li>
<li>Drug class: vitamin and mineral combinations</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Levomefolate, Calcium Acetylcysteine and Mecobalamin Algal &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Lexazin Capsules &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Multi Vitamin Infusion M.V.I. Adult &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Multi Vitamin Infusion M.V.I. Pediatric &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Dietary Supplementation</li>
<li>Hyperhomocysteinemia</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>